Recent advancements in molecular genetics and precision medicine have led to a broadening spectrum of cancer classifications. Alongside this, novel anti-cancer treatments like targeted therapy and immunotherapy are emerging. The significance of molecular pathology diagnosis is increasingly recognized, as it aids in diagnosing, prognosticating, and determining treatment approaches by analyzing genetic alterations and protein expression changes associated cancer. The Molecular Pathology Center plays a pivotal role in this process, aiming to enhance cancer patient care, elevate quality of life, and become a global leader of new cancer treatment method development.
Patient-specific molecular-integrated diagnosis system
Identifying individual molecular alterations in tissues or body fluids is crucial for diagnosing, prognosticating, and determining treatment plans for cancer patients. To achieve this, the Molecular Pathology Center employs various techniques, such as immunohistochemistry, Sanger sequencing, fluorescence in situ hybridization, polymerase chain reaction (PCR), real-time PCR, and Next Generation Sequencing (NGS). Five dedicated molecular pathology professors oversee the quality control of each test, while the entire pathology department manages the integration of cutting-edge molecular tests in their respective specialties.
Cooperative care by top-notch medical Staff
The professors at the Molecular Pathology Center conduct over 400 interdisciplinary conferences and multidisciplinary treatment (MDT) clinics annually, to provide accurate diagnosis and personalized care.